Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-2

MT-II, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2

Quick Stats
Studies 3
Trials 100
Recruiting OBSERVATIONAL NCT05334069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Detailed Description

PRIMARY OBJECTIVE: I. To provide a blinded reference set of cancer versus (vs.) non-cancer blood samples that will be used to validate assays for inclusion in a prospective clinical trial focused on utility of blood-based multi-cancer early detection. SECONDARY OBJECTIVES: I. Evaluate test performance at the time of initial cancer diagnosis by tumor type. II. Evaluate test performance at the time of initial cancer diagnosis by clinical stage. OUTLINE: Participants complete a questionnaire at baseline. Participants undergo collection of blood samples at registration and at 12 months after registration. Patients with a cancer diagnosis may undergo collection of tissue samples at registration and 12 months after registration. After completion of study, participants are followed up at 1 year.

Interventions

Name: Questionnaire Administration
Type: OTHER
Description: Complete questionnaire
Name: Biospecimen Collection
Type: PROCEDURE
Description: Undergo collection of tissue and blood samples

Primary Outcomes

Measure: Provision of blinded reference set of cancer versus non-cancer blood samples
TimeFrame: Up to 1 year
Description: Diagnostic ability will be assessed across the entire cohort of 2000 subjects by estimating the sensitivity and specificity with 95% confidence intervals.

Trial Information

NCT ID

NCT05334069

Status

Recruiting

Study Type

OBSERVATIONAL

Sponsor

Alliance for Clinical Trials in Oncology

Last Updated

December 15, 2025

Related Peptides